[1]
Marques, F.C. et al. 2026. Efficacy and safety of capivasertib for breast cancer patients: a systematic review and metaanalysis of randomized controlled trials. Mastology. 35, suppl.1 (Feb. 2026). DOI:https://doi.org/10.29289/259453942025V35S1023.